ATE131064T1 - Behandlung zur ermässigung von ödem und muskelschäden. - Google Patents

Behandlung zur ermässigung von ödem und muskelschäden.

Info

Publication number
ATE131064T1
ATE131064T1 AT90909011T AT90909011T ATE131064T1 AT E131064 T1 ATE131064 T1 AT E131064T1 AT 90909011 T AT90909011 T AT 90909011T AT 90909011 T AT90909011 T AT 90909011T AT E131064 T1 ATE131064 T1 AT E131064T1
Authority
AT
Austria
Prior art keywords
brain
edema
corticotropin
musculature
injury
Prior art date
Application number
AT90909011T
Other languages
English (en)
Inventor
Edward T Wei
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE131064T1 publication Critical patent/ATE131064T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90909011T 1989-07-28 1990-05-30 Behandlung zur ermässigung von ödem und muskelschäden. ATE131064T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/386,885 US5137871A (en) 1989-07-28 1989-07-28 Treatment to reduce edema for brain and musculature injuries

Publications (1)

Publication Number Publication Date
ATE131064T1 true ATE131064T1 (de) 1995-12-15

Family

ID=23527476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909011T ATE131064T1 (de) 1989-07-28 1990-05-30 Behandlung zur ermässigung von ödem und muskelschäden.

Country Status (11)

Country Link
US (2) US5137871A (de)
EP (1) EP0484340B1 (de)
JP (1) JP3012319B2 (de)
AT (1) ATE131064T1 (de)
AU (1) AU641166B2 (de)
CA (1) CA2064039C (de)
DE (1) DE69024053T2 (de)
DK (1) DK0484340T3 (de)
ES (1) ES2081989T3 (de)
IE (1) IE63053B1 (de)
WO (1) WO1991001997A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488033A (en) * 1989-07-28 1996-01-30 The Regents Of The University Of California Treatment to reduce edema
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries
US5374621A (en) * 1991-09-13 1994-12-20 Regents Of The University Of California Neurotensin method for inhibiting vascular leakage
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
EP0781140A4 (de) * 1994-09-12 1999-11-03 Univ Pennsylvania Die corticotropinfreisetzung inhibierender faktor und verfahren zu seiner nutzung
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
EP1579871A1 (de) * 1998-12-22 2005-09-28 Genentech, Inc. Antagonisten von vaskular-endothelialen Zellwachstumsfaktoren und ihre Anwendung
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
GB0415359D0 (en) * 2004-07-08 2004-08-11 Aimsco Ltd Medicament
BRPI0513062A (pt) * 2004-07-08 2008-04-22 Aimsco Ltd composição farmacêutica, método de estimular a produção de pomc em um paciente, usos de um peptìdeo de crf isolado e de um peptìdeo de pomc isolado, e, métodos de tratamento para uma doença, de produzir crf e de tratamento curativo, melhorador ou profilático de uma doença
GB0600202D0 (en) * 2006-01-06 2006-02-15 Aimsco Ltd Treatment of HIV
US7455447B2 (en) * 2006-05-19 2008-11-25 Mediatek Inc. Method and apparatus for a portable device
EP2350118B1 (de) 2008-09-19 2016-03-30 Nektar Therapeutics Kohlenhydratbasisierte polymere zur wirkstoffabgabe und konjugate davon
CN104602682B (zh) 2012-05-08 2018-12-14 埃罗米克斯公司 用于治疗水通道蛋白介导的疾病的化合物
EP3065729A4 (de) 2013-11-06 2017-05-31 Aeromics, Inc. Neuartige formulierungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
US4404198A (en) * 1979-01-24 1983-09-13 Beecham Inc. Phenyl Salicylate as a topical anti-inflammatory
US4415558A (en) * 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
AU9054582A (en) * 1982-09-29 1984-04-24 Lederis, K.P., Mac Cannell, K.L.:ichikawa, T:river, J.E. Urotensin peptides
US4528189A (en) * 1983-02-03 1985-07-09 The Salk Institute For Biological Studies Urotensin peptides
US4489163A (en) * 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
US4605642A (en) * 1984-02-23 1986-08-12 The Salk Institute For Biological Studies CRF antagonists
US4594329A (en) * 1984-05-14 1986-06-10 The Salk Institute For Biological Studies CRF analogs
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries

Also Published As

Publication number Publication date
DE69024053T2 (de) 1996-07-04
US5306710A (en) 1994-04-26
WO1991001997A1 (en) 1991-02-21
US5137871A (en) 1992-08-11
EP0484340B1 (de) 1995-12-06
IE63053B1 (en) 1995-03-22
AU5749290A (en) 1991-03-11
CA2064039C (en) 2001-01-02
AU641166B2 (en) 1993-09-16
JP3012319B2 (ja) 2000-02-21
JPH05501856A (ja) 1993-04-08
DE69024053D1 (de) 1996-01-18
EP0484340A1 (de) 1992-05-13
EP0484340A4 (en) 1993-02-17
IE902737A1 (en) 1991-02-27
CA2064039A1 (en) 1991-01-29
DK0484340T3 (da) 1996-04-22
ES2081989T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
DE69709682T2 (de) Gruene salbe
DE69024053D1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
Sistrunk Contribution to plastic surgery: Removal of scars by stages; an open operation for extensive laceration of the anal sphincter; the Kondoleon operation for elephantiasis
DE60115433T2 (de) Verfahren zur behandlung von chronischen geschwüren
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
Hartzell The use of living fascia transplant to repair a hernia of the tibialis anticus muscle
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
SU1711896A1 (ru) Способ лечени длительно незаживающих ран
RU2281089C2 (ru) Способ лечения открытого перелома конечности
Kubáček Complete avulsion of skin of penis and scrotum
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
RU2092121C1 (ru) Способ кожной ауто- и гомотрансплантации
Ross et al. Treatment of 100 war wounds and burns
RU2177303C2 (ru) Способ лечения ортопедических больных периартикулярным введением препарата
RU2020933C1 (ru) Стимулятор репаративной регенерации тканей
RU2014020C1 (ru) Способ лечения стилоидита
Warthen Jr The treatment of burns complicated by fractures of the extremities
SU1119676A1 (ru) Способ обезболивани при повреждени х костей таза
SU1491507A1 (ru) Способ подготовки к протезированию больных с культ ми нижних конечностей
SU1521463A1 (ru) Способ получени эпидермального трансплантата
Coryllos et al. Treatment of an avulsed skin-flap involving the circumference of the entire lower leg: a case report
Kiehn Progress attained in the search for the primary healing of gunshot wounds of the extremities in the ETO in World War II
Fackelman A new technique of skin transplantation and a preliminary evaluation of the effects of solcoseryl on graft acceptance
RU2092113C1 (ru) Способ лечения папиллом кожи
Tarshis Surgical maggots in modern medicine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time